Renalytix PLC
LSE:RENX

Watchlist Manager
Renalytix PLC Logo
Renalytix PLC
LSE:RENX
Watchlist
Price: 10.75 GBX 7.93% Market Closed
Market Cap: 35.6m GBX
Have any thoughts about
Renalytix PLC?
Write Note

P/E
Price to Earnings

-1
Current
-5.9
Median
23.1
Industry
Higher than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-1
=
Market Cap
35.6m GBX
/
Net Income
-46.2m USD
All Countries
Close
Earnings Growth P/E to Growth
UK
Renalytix PLC
LSE:RENX
Average P/E: 105
Negative Multiple: -1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
52.9
142%
0.4
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
AU
Pro Medicus Ltd
ASX:PME
315.6
131%
2.4
US
Doximity Inc
NYSE:DOCS
62.5
78%
0.8
US
W
Waystar Holding Corp
NASDAQ:WAY
Negative Multiple: -123.5 N/A N/A
JP
M3 Inc
TSE:2413
23.7
33%
0.7
US
Inspire Medical Systems Inc
NYSE:INSP
168.9
N/A N/A
SE
Sectra AB
STO:SECT B
118.9
81%
1.5
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -293.9 N/A N/A
CN
Winning Health Technology Group Co Ltd
SZSE:300253
44.2
142%
0.3

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-0
2-Years Forward
P/E
-0
3-Years Forward
P/E
-0

See Also

Discover More